Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint Inhibitors

Introduction: In the current study, we aimed to assess the impact of antibiotics (ATB) and metabolic parameters on clinical outcome of non-small cell lung carcinoma (NSCLC) patients treated with immune checkpoint inhibitors (ICI). Methods: Data from fifty NSCLC patients referred for ICI between Dece...

Descripción completa

Detalles Bibliográficos
Autores principales: Castello, Angelo, Rossi, Sabrina, Toschi, Luca, Lopci, Egesta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002619/
https://www.ncbi.nlm.nih.gov/pubmed/33803006
http://dx.doi.org/10.3390/jcm10061251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002619/
https://www.ncbi.nlm.nih.gov/pubmed/33803006
http://dx.doi.org/10.3390/jcm10061251

Ejemplares similares